Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Biochim Biophys Acta. 2015 Dec 17;1863(4):562–571. doi: 10.1016/j.bbamcr.2015.12.008

Table 1.

AML Patient Charateristics.

AML
Patient #		 Age Gender Diagnosis % BM
blasts		 Cytogenetics Other molecular
parameters
1 85 M Therapy-related mixed phenotype Ph+ acute leukemia 52 Complex, t(9;22), −5, −7, -Y e1a2 BCR-ABL1 fusion TET2 Q810*
2 64 M AML with recurrent genetic abnormality 78 Complex, t(6;9), +8, +13 t(6;9)(p23;q34); DEK-NUP214 FLT3-ITD
3 75 F AML without maturation (FAB M1) 86 Normal DNMT3A G590fs*21 DNMT3A K589N NPM1 W288fs*12 TET2 Q909* FLT3-ITD